Graft Function clinical trials

Explore recruiting graft function clinical trials.

Recruiting graft function studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Graft Function trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

CASPER-ATG-IPC 2023-015 : Reinforced prophylaxis of GVH in elderly patients with haematological malignancies receiving haploidentical allogeneic hematopoietic stem cell transplantation: use of a low dose of post-allograft anti-lymphocytic serum.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft at Risk for Delayed Graft Function (Varvara)

Belgium, Spain, Portugal, Italy, France, Austria +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Spain, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function after Kidney Transplantation

Poland, Italy, Germany, Austria, Portugal, Czechia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Graft Function trials by city

Graft Function in Toronto Graft Function in Vancouver Graft Function in Montreal Graft Function in Calgary Graft Function in Edmonton Graft Function in Ottawa Graft Function in Winnipeg Graft Function in Quebec City Graft Function in Hamilton Graft Function in Kitchener Graft Function in London Graft Function in Halifax Graft Function in New York Graft Function in Los Angeles Graft Function in Chicago Graft Function in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease